Contrast media injectors are used to inject contrast media or contrast agents to improve blood and tissue perfusion to enhance the medical imaging procedure. Contrast delivery is also known as a power injector and is the most flexible therapeutic device that can be designed to deliver accurate measurements of contrast agents at a varying flow rate. Contrast media injectors can be utilized in diagnosis of internal injuries, diagnosis and monitoring cancer, vascular disease, heart disease, and gastrointestinal disorders among others. The major factors driving the growth of the market are increasing investment & funds, government grants, a large number of contrast agent approvals, and rising scope of clinical applications along with increasing demand for early diagnosis. In addition, rising number of private and public diagnostic centers further contribute to the growth of the global market. However, high costs associated with the contrast media injectors and consumables & accessories, lack of trained professionals, and risks associated with the contrast media injectors are likely to hinder the growth of the industry.

CT injector systems is expected to hold the largest revenue in the injectors segment

Contrast injectors are widely used to inject computed tomography iodine-based contrast agents that are called as CT injectors. The considerable growth in the number of imaging procedures in recent years has increased the demand for CT systems. Therefore, CT systems are anticipated to show positive growth in the global contrast media injectors & agents market. In addition, rising awareness related to various health issues and an increasing number of installations of CT scanners further fueling the significant growth in the global market.

North America spearheads the global market during the forecast period

Geographically, the global market is classified into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. North America is likely to dominate the global market during the forecast period due to factors such as the rising prevalence of the chronic disease, and a growing preference for minimally invasive procedures. Besides, technological advancement in contrast media injector devices and increased healthcare expenditure along with increasing investment in R&D sectors by key players further contribute to the growth of the market in North America.

Key Market Players

• Bayer AG
• Bracco Imaging S.P.A
• Guerbet Group
• Ulrich GmbH & Co. KG
• Nemoto Kyorindo Co., Ltd
• Sino Medical-Device Technology Co., Ltd.
• APOLLO RT Co. Ltd.
• Shenzhen Anke High-tech Co. Ltd
• Shenzen Seacrown Electromechanical Co Ltd.
• Medtron AG
• GE Healthcare

Market Segments: Global Contrast Media Injectors & Agents

• By Products
  • Injector Systems
    • CT Injector Systems
    • MRI Injector Systems
    • Cardiovascular/Angiography Injector Systems
  • Consumables
    • Tubing
    • Syringe
• By Type of Injectors
  • Single-head Injectors
  • Dual-head Injectors
  • Syringeless Injectors
• By Application
  • Radiology
  • Interventional Cardiology
  • Other Applications
• By End User
  • Hospitals
  • Diagnostic Imaging Centers
• By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • India
    • Japan
  • Middle East & Africa
    • UAE
    • South Africa
  • Central & South America
    • Brazil
    • Mexico

Key Sources

• Industry Associations
• Research Papers
• Company Annual Reports
• Company Websites
• Key Industry Leaders
• Technology Consultants
• Others

Key Questions Answered

• What are the key growth regions and countries?
• What are the important types and technologies being used?
• What are the market players doing, in terms of research and development?
• What is the recent news, developments, mergers, or large value deals?
• Where will the industry go in the long run?

Key Stakeholders

• Research & consulting firms, venture capitalists, private equity firms, and startup companies
• Contrast media devices manufacturers, suppliers, and distributors
• Pharmaceutical and biotechnology companies
• Healthcare institutions
• Diagnostic and imaging centers
• Clinical research centers
• Academic medical centers and universities
• Business research and consulting firms
• Government and regulatory authorities